Predicting Pre-Eclampsia

Predicting Pre-Eclampsia

BioPharma Predicting Pre-Eclampsia Pre-eclampsia, a condition affecting pregnant women, remains poorly understood despite affecting up to one in ten pregnancies worldwide. The condition kills 70,000 mothers and half a million babies globally each year. If diagnosed...
Predicting dementia nine years before symptoms

Predicting dementia nine years before symptoms

BioPharma Predicting dementia nine years before symptoms Researchers at Queen Mary’s Centre of Preventive Neurology have developed a new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis. The new method provides a more...
A Combination Therapy for Neovascular Eye Diseases

A Combination Therapy for Neovascular Eye Diseases

BioPharma A Combination Therapy for Neovascular Eye Diseases Angiogenesis is a leading cause of eye problems among over 50s – including blindness. Conventional treatments have serious side effects, making them deeply unpleasant for patients. A new peptide therapy...
Reversing tumour resistance to kinase inhibitors

Reversing tumour resistance to kinase inhibitors

BioPharma Reversing tumour resistance to kinase inhibitors Drug resistance is behind most relapses in cancer patients. This is partly why anti-cancer drugs targeting oncogenic kinase signalling have failed to live up to expectations. Kinase inhibitors are only...
Restorative treatments for osteoarthritis

Restorative treatments for osteoarthritis

BioPharma Restorative treatments for osteoarthritis There’s no cure for osteoarthritis. Current treatment for this debilitating joint disease involves managing symptoms and replacing joints. Professor Francesco Dell’Accio and his team have invented three novel and...